GRP
SLNO

Global Retirement Partners’s Soleno Therapeutics SLNO Stock Holding History

Global Retirement Partners’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$28.7K Buy
619
+519
+519% +$28.5K ﹤0.01% 2696
2025
Q3 		$6.76K Sell
100
-400
-80% -$29.7K ﹤0.01% 2854
2025
Q2 		$41.9K Buy
+500
New +$37.4K ﹤0.01% 1867
2024
Q4 		$4.5K Hold
100
– – ﹤0.01% 2730
2024
Q3 		$5.05K Hold
100
– – ﹤0.01% 2552
2024
Q2 		$4.08K Buy
100
+30
+43% +$1.27K ﹤0.01% 2694
2024
Q1 		$3K Buy
+70
New +$3.17K ﹤0.01% 2589

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Global Retirement Partners's SLNO Position: Q4 2025 in Review

Global Retirement Partners increased its Soleno Therapeutics (SLNO) stake by 519% in Q4 2025, buying an estimated $28.5K and bringing the position to 619 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

Global Retirement Partners first reported a position in SLNO in Q1 2024 and has held it in 7 quarters since. The position peaked at $41.9K in Q2 2025. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

  • Global Retirement Partners held 619 shares of Soleno Therapeutics worth $28.7K as of Q4 2025.
  • Global Retirement Partners bought 519 Soleno Therapeutics shares in Q4 2025, an estimated $28.5K.
  • Soleno Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2696 holding.
  • Global Retirement Partners first reported a position in Soleno Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Global Retirement Partners's Soleno Therapeutics position peaked at $41.9K in Q2 2025.
  • 248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.